Showing 551 - 560 of 1,415
Cost-effectiveness analysis has been advocated in the health economics methods literature and adopted in a growing number of jurisdictions as an evidence base for decision makers charged with maximising health gains from available resources. This paper critically appraises the information...
Persistent link: https://www.econbiz.de/10005404817
Objective: The aim of this study was to determine the relative economic consequences of treating asthmatics with twice daily dry powder formoterol 12microg as compared with salmeterol 50microg from a societal perspective. Design and Setting: A randomised, 6-month, open-label study including 482...
Persistent link: https://www.econbiz.de/10005404819
Objective: To evaluate the effect of using different cost-effectiveness measures in the economic evaluation of cholesterol-modifying pharmacotherapy. Design and setting: An economic model was used to examine the extent to which the relative cost effectiveness of cholesterol-modifying agents...
Persistent link: https://www.econbiz.de/10005404830
Persistent link: https://www.econbiz.de/10005404844
Alcoholism places a considerable economic burden on society. The rate of relapse of previously weaned alcoholics has been shown to decrease following treatment with acamprosate. Therefore, this study investigated the cost effectiveness of acamprosate in the treatment of alcoholism in Germany...
Persistent link: https://www.econbiz.de/10005404846
Chronic hepatitis C virus (HCV) infection affects 170 million individuals worldwide. As it is detected incidentally through the evaluation of liver function tests or at the time of blood donor testing, it is usually clinically silent until the advanced stages of liver disease have occurred, when...
Persistent link: https://www.econbiz.de/10005404847
The introduction of expensive disease-modifying agents for the treatment of multiple sclerosis (MS) has created the potential for patients with MS to become higher contributors to healthcare spending. In an attempt to make formulary and reimbursement choices for these agents, decision-makers may...
Persistent link: https://www.econbiz.de/10005404866
This paper provides an overview of, and guidance as to when, why and how to choose and use, different simulation modelling methods as applied to healthcare. What simulation is and why it is necessary in addressing healthcare problems are discussed. In addition, key criteria for choosing an...
Persistent link: https://www.econbiz.de/10005404870
The objective of this review was to identify health-related workplace productivity loss survey instruments, with particular emphasis on those that capture a metric suitable for direct translation into a monetary figure. A literature search using Medline, HealthSTAR, PsycINFO and Econlit...
Persistent link: https://www.econbiz.de/10005404872
Persistent link: https://www.econbiz.de/10005404889